SEC Form 4 · accession 0001437749-15-016347
LIFECORE BIOMEDICAL, INC. \DE\ · LFCR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert Tobin
Director
Period of report
Aug 21, 2015
Accepted (ET)
Aug 24, 2015 · 5:48 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001005286
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 21, 2015 | M | 10,000 | $6.85 | A | 36,227 | D | |
| Common StockF1 | Aug 21, 2015 | F | 5,359 | $12.78 | D | 30,868 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NonQualified Stock Option (Right to Buy) | $12.78 | Aug 21, 2015 | X | 10,000 | D | Oct 14, 2005 | Oct 14, 2015 | Common Stock | 10,000 | 0 | D |
Explanation of responses
- F1Mr. Tobin surrendered to the Issuer the right to receive an aggregate of 5,359 shares of Common Stock. Mr. Tobin did not sell any shares of Common Stock in connection with the foregoing exercise.